Matches in SemOpenAlex for { <https://semopenalex.org/work/W3008910447> ?p ?o ?g. }
- W3008910447 endingPage "522" @default.
- W3008910447 startingPage "522" @default.
- W3008910447 abstract "Eating disorders (EDs) are increasingly frequent. Their pathophysiology involves disturbance of peptide signaling and the microbiota–gut–brain axis. This study analyzed peptides and corresponding immunoglobulin (Ig) concentrations in groups of ED. In 120 patients with restrictive (R), bulimic (B), and compulsive (C) ED, the plasma concentrations of leptin, glucagon-like peptide-1 (GLP-1), peptide YY (PYY), and insulin were analyzed by Milliplex and those of acyl ghrelin (AG), des-acyl ghrelin (DAG), and α-melanocyte-stimulating hormone (α-MSH) by ELISA kits. Immunoglobulin G (in response to an antigen) concentrations were analyzed by ELISA, and their affinity for the respective peptide was measured by surface plasmon resonance. The concentrations of leptin, insulin, GLP-1, and PYY were higher in C patients than in R patients. On the contrary, α-MSH, DAG, and AG concentrations were higher in R than in C patients. After adjustment for body mass index (BMI), differences among peptide concentrations were no longer different. No difference in the concentrations of the IgG was found, but the IgG concentrations were correlated with each other. Although differences of peptide concentrations exist among ED subtypes, they may be due to differences in BMI. Changes in the concentration and/or affinity of several anti-peptide IgG may contribute to the physiopathology of ED or may be related to fat mass." @default.
- W3008910447 created "2020-03-06" @default.
- W3008910447 creator A5000341174 @default.
- W3008910447 creator A5001785801 @default.
- W3008910447 creator A5008743296 @default.
- W3008910447 creator A5009354609 @default.
- W3008910447 creator A5014258346 @default.
- W3008910447 creator A5018987446 @default.
- W3008910447 creator A5021534573 @default.
- W3008910447 creator A5023235445 @default.
- W3008910447 creator A5024511606 @default.
- W3008910447 creator A5032617162 @default.
- W3008910447 creator A5034549468 @default.
- W3008910447 creator A5034575041 @default.
- W3008910447 creator A5034906246 @default.
- W3008910447 creator A5036927676 @default.
- W3008910447 creator A5040224319 @default.
- W3008910447 creator A5041245943 @default.
- W3008910447 creator A5073099637 @default.
- W3008910447 creator A5080479738 @default.
- W3008910447 creator A5085580681 @default.
- W3008910447 creator A5086009721 @default.
- W3008910447 creator A5089818862 @default.
- W3008910447 creator A5091345073 @default.
- W3008910447 creator A5091764971 @default.
- W3008910447 date "2020-02-18" @default.
- W3008910447 modified "2023-09-26" @default.
- W3008910447 title "Plasma Peptide Concentrations and Peptide-Reactive Immunoglobulins in Patients with Eating Disorders at Inclusion in the French EDILS Cohort (Eating Disorders Inventory and Longitudinal Survey)" @default.
- W3008910447 cites W1534057962 @default.
- W3008910447 cites W1964373020 @default.
- W3008910447 cites W1964863934 @default.
- W3008910447 cites W1976198811 @default.
- W3008910447 cites W1976556799 @default.
- W3008910447 cites W1983240363 @default.
- W3008910447 cites W1987327892 @default.
- W3008910447 cites W1992565586 @default.
- W3008910447 cites W2002562230 @default.
- W3008910447 cites W2014632252 @default.
- W3008910447 cites W2028553430 @default.
- W3008910447 cites W2032938877 @default.
- W3008910447 cites W2033448482 @default.
- W3008910447 cites W2034872246 @default.
- W3008910447 cites W2037226098 @default.
- W3008910447 cites W2039033342 @default.
- W3008910447 cites W2039275310 @default.
- W3008910447 cites W2044208883 @default.
- W3008910447 cites W2045613228 @default.
- W3008910447 cites W2046626308 @default.
- W3008910447 cites W2053859901 @default.
- W3008910447 cites W2054326484 @default.
- W3008910447 cites W2054395690 @default.
- W3008910447 cites W2068406864 @default.
- W3008910447 cites W2075832262 @default.
- W3008910447 cites W2078060668 @default.
- W3008910447 cites W2082052031 @default.
- W3008910447 cites W2090523262 @default.
- W3008910447 cites W2093630227 @default.
- W3008910447 cites W2097526794 @default.
- W3008910447 cites W2097546680 @default.
- W3008910447 cites W2106572906 @default.
- W3008910447 cites W2108280548 @default.
- W3008910447 cites W2110505933 @default.
- W3008910447 cites W2114292319 @default.
- W3008910447 cites W2120237383 @default.
- W3008910447 cites W2131056279 @default.
- W3008910447 cites W2135303854 @default.
- W3008910447 cites W2138123424 @default.
- W3008910447 cites W2138492108 @default.
- W3008910447 cites W2139979797 @default.
- W3008910447 cites W2140666083 @default.
- W3008910447 cites W2151670857 @default.
- W3008910447 cites W2158877339 @default.
- W3008910447 cites W2163146086 @default.
- W3008910447 cites W2168264507 @default.
- W3008910447 cites W2169705598 @default.
- W3008910447 cites W2171309451 @default.
- W3008910447 cites W2171545814 @default.
- W3008910447 cites W2276066357 @default.
- W3008910447 cites W2315196237 @default.
- W3008910447 cites W2318435945 @default.
- W3008910447 cites W2375682831 @default.
- W3008910447 cites W2407695395 @default.
- W3008910447 cites W2519262962 @default.
- W3008910447 cites W2560609297 @default.
- W3008910447 cites W2570578408 @default.
- W3008910447 cites W2754200634 @default.
- W3008910447 cites W2896757487 @default.
- W3008910447 cites W2911671507 @default.
- W3008910447 cites W2940909888 @default.
- W3008910447 cites W4241277272 @default.
- W3008910447 doi "https://doi.org/10.3390/nu12020522" @default.
- W3008910447 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7071399" @default.
- W3008910447 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32085628" @default.
- W3008910447 hasPublicationYear "2020" @default.
- W3008910447 type Work @default.
- W3008910447 sameAs 3008910447 @default.
- W3008910447 citedByCount "6" @default.
- W3008910447 countsByYear W30089104472021 @default.